Hormonal contraception and sexual desire: A critical review

Journal of Sex and Marital Therapy

Volumn 32, Issue 4, 2006, Pages 305-314

  Schaffir, Jonathan ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b 516 Means Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE;

ARTICLE; BREAKTHROUGH BLEEDING; CULTURAL FACTOR; ERECTILE DYSFUNCTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL CONTRACEPTION; HUMAN; LIBIDO DISORDER; MOOD; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SOCIAL ASPECT; TESTOSTERONE BLOOD LEVEL; WELLBEING;

AFFECT; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSION; FEMALE; HUMANS; LIBIDO; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; WOMEN'S HEALTH;

EID: 33745699790     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926230600666311     Document Type: Article

References (32)

1. Aedo, A. R., Landgren, B. M., & Diczfalusy, E. (1981). Studies on ovarian and adrenal steroids at different phases of the menstrual cycle: III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depotmedroxyprogesterone acetate. Contraception, 24, 117-135.
2. Alexander, G. M., Sherwin, B. B., Bancroft, J., &Davidson, D. W. (1990). Testosterone and sexual behavior in oral contraceptive users and non-users: A prospective study. Hormones and Behavior, 24, 388-402.
3. Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., Goldstein, I., Guay, A., Leiblum, S., Lobo, R., Notelovitz, M., Rosen, R., Sarrel, P., Sherwin, B., Simon, J., Simpson, E., Shifren, J., Spark, R., & Traish, A. (2002). Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertility and Sterility, 77, 660-665.
4. Bancroft, J., Davidson, D. W., Warner, P., & Tyrer, G. (1980). Androgens and sexual behaviour in women using oral contraceptives. Clinical Endocrinology, 12, 327-340.
5. Bancroft, J., Sherwin, B. B., Alexander, G. M., Davidson, D. W., & Walker, A. (1991). Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens. Archives of Sexual Behavior, 20, 121-135.
6. Barnhart, K. T., Furman, I., Pommer, R., Coutinho, E., & Devoto, L. (1997). Changes in the menstrual bleeding of users of a subdermal contraceptive implant of nomogestrol acetate (Uniplant) do not influence sexual frequency, sexual desire, or sexual enjoyment. Fertility and Sterility, 67, 244-249.
7. Berman, J. R., Berman, L., & Goldstein, I. (1999). Female sexual dysfunction: Incidence, pathophysiology, evaluation and treatment options. Urology, 54, 385-391.
8. Bitzer, J., Tschudin, S., Meier-Burgoa, J., Armbruster, U., & Schwendke, A. (2003) Einfluss eines neuen oralen Kontrazeptivums mit 30 mcg EE und 3 mg Drospirenon (Yasmin) auf die Lebensqualitat. (Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)). Schweizerische Rundschau fur Medizin Praxis, 92, 1177-1184.
9. Brache, V., Faundes, A., Alvarez, F., & Cochon, L. (2002). Nonmenstrual adverse events during use of implantable contraceptives for women: Data from clinical trials. Contraception, 65, 63-74.
10. Bragonier, J. R. (1976). Influence of oral contraception on sexual response. Medical Aspects of Human Sexuality, 10, 130, 133-137, 143.
11. Clayton, A. H. (2003). Sexual function and dysfunction in women. Psychiatric Clinics of North America, 26, 673-682.
12. Dennerstein, L., & Burrows, G. (1976). Oral contraception and sexuality. Medical Journal of Australia, 1, 796-798.
13. Dennerstein, L., Gotts, G., Brown, J. B., Morse, C. A., Farley, T. M. M., & Pinol, A. (1994). The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers. Psychoneuroendocrinology, 19, 293-304.
14. Fucs, G. B., & Coutinho, E. M. (1975). Treatment of diminished sexual response associated with the use of oral contraceptives. Reproduccion, 2, 97-104.
15. Gambrell, Jr, R. D., Bernard, D. M., Sanders, B. I., Vanderburg, N., & Buxton, S. J. (1976). Changes in sexual drives of patients on oral contraceptives. Journal of Reproductive Medicine, 17, 165-171.
16. Graham, C. A., Ramos, R., Bancroft, J., Maglaya, C., Farley, & T. M. M. (1995). The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blinded, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception, 52, 363-369.
17. Graham, C. A., & Sherwin, B. B. (1993). The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology, 18, 273-281.
18. Granger, L. R., Roy, S., & Mishell, Jr, D. R. (1982). Changes in unbound sex steroids and sex hormone binding globulin-binding capacity during oral and vaginal progestogen administration. American Journal of Obstetrics and Gynecology, 144, 578-584.
19. Jung-Hoffman, C., & Kuhl, H. (1987). Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone. American Journal of Obstetrics and Gynecology, 156, 199-203.
20. Kiersch, T. A. (1990). Treatment of sex offenders with Depo-Provera. The Bulletin of the American Academy of Psychiatry and the Law, 18, 179-187.
21. Leeton, J., McMaster, R., & Worsley, A. (1978). The effects on sexual response and mood after sterilization of women taking long-term oral contraception: Results of a double-blind cross-over study. Australia and New Zealand Journal of Obstetrics and Gynecology, 18, 194-197.
22. Li, R. H. W., Lo, S. S. T., Teh, D. K. G., Tong, N.-C., Tsui, M. H. Y., Cheung, K.-B., Chung, & T. K. H. (2004). Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception, 70, 474-482.
23. Martin-Loeches, M., Orti, R. M., Monfort, M., Ortega, E., & Rius, J. (2003). A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices. European Journal of Contraception and Reproductive Health Care, 8, 129-134.
24. McCoy, N. L., & Matyas, J. R. (1996). Oral contraceptives and sexuality in university women. Archives of Sexual Behavior, 25, 73-90.
25. Onu, P. E. (1995). Depot medroxyprogesterone in the management of benign prostatic hyperplasia. European Urology, 28, 229-235.
26. Paul, C., Skegg, D. C. G., & Williams, S. (1997). Depot medroxyprogesterone acetate: Patterns of use and reasons for discontinuation. Contraception, 60, 81-85.
27. Persky, H., Dreisbach, L., Miller, W., O'Brien, C. P., Khan, M.A., Lief, H. I., Charney, N., & Strauss, D. (1982). The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosomatic Medicine, 44, 305-319.
28. Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64, 51-58.
29. Sarajari, S., Wickman, D. S., Marin, C. M., & Berman, J. R. (2004). Pilot study assessing the impact of hormonal contraceptives on serum testosterone levels and sexual function in pre-menopausal women. Fertility and Sterility, 82 (Suppl 2), S78-S79.
30. Sherwin, B. B., & Gelfand, M. M. (1987). The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosomatic Medicine, 49, 397-409.
31. Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., & Redmond, G. P. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 343, 682-688.
32. Warner, P., & Bancroft, J. (1988) Mood, sexuality, oral contraceptives and the menstrual cycle. Journal of Psychosomatic Research, 32, 417-427.